We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Sustained Release Therapies with the Prostaglandin Analogues Intracameral Implants.
- Authors
Elhusseiny, Abdelrahman M.; Aref, Ahmad A.
- Abstract
The travoprost intracameral implant was recently approved by the US Food and Drug Administration for sustained release medical treatment of open-angle glaucoma in the USA. The approval represents a substantial and progressive step forward in the area of sustained-release glaucoma therapy. Topical intraocular pressure-lowering medications for the treatment of glaucoma are faced with a host of challenges for long-term and usually lifelong care. A changing paradigm in glaucoma management involves first-line interventions with laser modalities, micro-invasive surgeries, and sustained-release treatment platforms. Future needs in the area of sustained-release therapy include a non-prostaglandin drug delivery platform and longer-term treatments that do not require surgical reintervention.
- Subjects
DRUG delivery systems; OPEN-angle glaucoma; PROSTAGLANDINS; THERAPEUTICS; TRABECULECTOMY; GLAUCOMA; FILTERING surgery; PRESSURE ulcers
- Publication
Ophthalmology & Therapy, 2024, Vol 13, Issue 7, p1833
- ISSN
2193-8245
- Publication type
Article
- DOI
10.1007/s40123-024-00965-4